Home Patent Forecast® Sectors Log In   Contact  
How it works Patent Forecast® Sectors Insights
Enjoy your FREE PREVIEW which shows only 2022 data and 25 documents. Contact Patent Forecast for full access.        


Read More News and Insights

Microalgal Biosynthesis of Cannabinoids

Z-ARCHIVE-Cannabis Patent Forecast®

July 16, 2020

Cannabinoid biosynthesis is a fast-growing market, with industries like pharmaceutical and food & beverage extremely interested. So far, the majority of host organisms used for synthesizing cannabinoids have been bacteria or fungi; however, a recent patent (US Pat. 10,704,066) was issued for using microalgal hosts in the genus Prototheca. 

Prototheca is a parasitic microalgae that causes protothecosis in animals including humans. The prototheca cells are engineered to produce cannabinoid synthases to then metabolize cannabinoids with. For more information on cannabinoid biosynthesis, check out this blog published by Magic Number.

Patent ‘066 is assigned to California-based Purissima Inc., a natural ingredients company deriving plant-based products from engineered biological microorganisms to produce in mass scale. For a closer look at the cannabinoid biosynthesis IP landscape, subscribe to the Magic Number Cannabis Patent Forecast®

Test Tube, Erlenmeyer Flask, Chemistry, Laboratory

Relevant Patent Documents

Patent US10704066  

Article Source Link

The Budding Promise of Cannabinoid Biosynthesis

Read more like this in News This Week!   or   Share this link with your connections!